Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Accumulated Expenses (2018 - 2025)

Exagen (XGN) has disclosed Accumulated Expenses for 8 consecutive years, with $6.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 8.52% year-over-year to $6.3 million, compared with a TTM value of $6.3 million through Dec 2025, down 8.52%, and an annual FY2025 reading of $6.3 million, down 8.52% over the prior year.
  • Accumulated Expenses was $6.3 million for Q4 2025 at Exagen, up from $5.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $7.5 million in Q4 2023 and bottomed at $4.9 million in Q2 2025.
  • Average Accumulated Expenses over 5 years is $6.1 million, with a median of $6.1 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses fell 21.67% in 2022, then surged 40.85% in 2023.
  • Year by year, Accumulated Expenses stood at $6.8 million in 2021, then fell by 21.67% to $5.3 million in 2022, then skyrocketed by 40.85% to $7.5 million in 2023, then fell by 8.17% to $6.9 million in 2024, then decreased by 8.52% to $6.3 million in 2025.
  • Business Quant data shows Accumulated Expenses for XGN at $6.3 million in Q4 2025, $5.7 million in Q3 2025, and $4.9 million in Q2 2025.